Repositorio Dspace

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Mostrar el registro sencillo del ítem

dc.contributor.author Daruwalla, Cyrus
dc.contributor.author Kremler, Courtney
dc.contributor.author Patti, Francesco
dc.contributor.author Ozakbas, Serkan
dc.contributor.author Boz, Cavit
dc.contributor.author Lechner-Scott, Jeannette
dc.contributor.author Surcinelli, Andrea
dc.contributor.author Foschi, Matteo
dc.contributor.author Khoury, Samia-J
dc.contributor.author Butzkueven, Helmut
dc.contributor.author van-der-Walt, Anneke
dc.contributor.author Rous, Zuzana
dc.contributor.author Habek, Mario
dc.contributor.author Meca-Lallana, José-Eustasio
dc.contributor.author López, Gabriel-Valero
dc.contributor.author Alroughani, Raed
dc.contributor.author Blanco, Yolanda
dc.contributor.author Laureys, Guy
dc.contributor.author Skibina, Olga
dc.contributor.author Buzzard, Katherine
dc.contributor.author Gray, Orla
dc.contributor.author McCombe, Pamela
dc.contributor.author Maimone, Davide
dc.contributor.author Duquette, Pierre
dc.contributor.author Girard, Marc
dc.contributor.author Prat, Alexandre
dc.contributor.author Sánchez-Menoyo, José-Luis
dc.contributor.author van-Pesch, Vincent
dc.contributor.author Soysal, Aysun
dc.contributor.author Amato, María-Pia
dc.contributor.author Grand'Maison, Francois
dc.contributor.author Wilton, Judith
dc.contributor.author Van-Wijmeersch, Bart
dc.contributor.author Gerlach, Oliver
dc.contributor.author Lugaresi, Alessandra
dc.contributor.author Tomassini, Valentina
dc.contributor.author De-Luca, Giovanna
dc.contributor.author Taylor, Bruce
dc.contributor.author Foong, Yi-Chao
dc.contributor.author John, Nevin
dc.contributor.author Cardenas-Robledo, Simon
dc.contributor.author Hodgkinson, Suzanne
dc.contributor.author Macdonell, Richard
dc.contributor.author Willekens, Barbara
dc.contributor.author Garber, Justin
dc.contributor.author D'Amico, Emanuele
dc.contributor.author Terzi, Murat
dc.contributor.author Houskova, Jana
dc.contributor.author Lapointe, Emmanuelle
dc.contributor.author Al-Asmi, Abdullah
dc.contributor.author Barnett, Michael
dc.contributor.author Stetkarova, Ivana
dc.contributor.author Gouider, Riadh
dc.contributor.author Mrabet, Saloua
dc.contributor.author Csepany, Tunde
dc.contributor.author McGuigan, Chris
dc.contributor.author Gross-Paju, Katrin
dc.contributor.author Kuhle, Jens
dc.contributor.author Castillo-Trivino, Tamara
dc.contributor.author Kerrigan, Simon
dc.contributor.author Tolkovsky, Aviva-M
dc.contributor.author Wardle, Mark
dc.contributor.author Cunniffe, Nick-G
dc.contributor.author Roos, Izanne
dc.contributor.author Madley-Dowd, Paul
dc.contributor.author Coles, Alasdair
dc.contributor.author Kalincik, Tomas
dc.contributor.author Sterne, Jonathan-A-C
dc.contributor.author William-Brown, J-L
dc.date.accessioned 2026-11-11T09:05:34Z
dc.date.available 2026-11-11T09:05:34Z
dc.date.issued 2026-07-24
dc.identifier.citation Daruwalla C, Kremler C, Patti F, Ozakbas S, Boz C, Lechner-Scott J, et al. Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis. Brain. 24 de julio de 2026;awag252. doi:10.1093/brain/awag252
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/29176
dc.description.abstract Clinically silent MRI lesions occur frequently in people with relapsing-remitting multiple sclerosis (RRMS) despite disease modifying therapy (DMT). Guidelines only routinely recommend DMT escalation after multiple silent lesions, and adherence is variable. We explored outcomes and the effect of treatment escalation following single and multiple on-treatment silent lesions. This cohort study and emulated target trial used MSBase registry data from 99 clinics in 26 countries between 2007 and 2025. Clinically stable participants receiving any DMT for RRMS with silent lesions versus without silent lesions were compared. Among participants with silent lesions while taking platform or moderate-efficacy DMTs, outcomes following treatment escalation within 6 months versus no treatment escalation (unless a post-MRI clinical event occurred) were compared. The primary outcome was an MS relapse, and the secondary outcome was 6-month confirmed disability worsening. A total of 10,232 participants met inclusion criteria (71.7% female, mean age 41 [SD 11]). The 2-year cumulative incidence of relapse was 27.8% (95% CI: 25.7%-29.9%) in participants with silent lesions versus 14.3% (95% CI: 13.5%-15.2%) without (adjusted hazard ratio [aHR] 1.76 [95% CI: 1.57-1.97]). The 2-year cumulative incidence of disability worsening was 13.8% (95% CI: 12.2%-15.5%) in participants with silent lesions versus 11.4% (95% CI: 10.7%-12.2%) without (aHR 1.38 [95% CI: 1.18-1.62]). Rates of relapse and disability worsening were higher following single and multiple silent lesions versus no silent lesions. The emulated trial included 2,264 participants with ?1 silent lesion on platform or moderate efficacy DMTs, 286 of whom escalated DMT within 6 months following silent lesions. The 4-year cumulative incidence of relapse was lower following treatment escalation (16.8% [95% CI: 12.4%-23.4%]) versus continuation (38.9% [95% CI: 35.8%-42.1%]), aHR 0.34 (95% CI: 0.23-0.47), with similar aHRs following single and multiple silent lesions. The 4-year cumulative incidence of disability worsening was similar following treatment escalation (16.0% [95% CI: 10.8%-22.2%]) versus continuation (17.7% [95% CI: 15.3%-20.1%]), aHR 0.89 (95% CI: 0.56-1.33). People with RRMS with single or multiple on-treatment silent MRI lesions have higher subsequent risks of relapse and disability worsening than people without silent lesions. DMT escalation mitigates the relapse risk, though disability worsening continues at a similar rate over 4 years. Contrary to guidelines, DMT escalation should be considered after single or multiple silent lesions.
dc.language.iso eng
dc.publisher OXFORD UNIVERSITY PRESS (OUP)
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.title Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 42496160
dc.relation.publisherversion https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awag252/8741305
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1093/brain/awag252
dc.journal.title Brain : A Journal of Neurology
dc.identifier.essn 1460-2156


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta